Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9426
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGilligan, A Ken
dc.contributor.authorMarkus, Romeshen
dc.contributor.authorRead, Stephen Jen
dc.contributor.authorSrikanth, Ven
dc.contributor.authorHirano, Ten
dc.contributor.authorFitt, Gregory Jen
dc.contributor.authorArends, Men
dc.contributor.authorChambers, Brian Ren
dc.contributor.authorDavis, S Men
dc.contributor.authorDonnan, Geoffrey Aen
dc.date.accessioned2015-05-15T22:31:06Z
dc.date.available2015-05-15T22:31:06Z
dc.date.issued2002-09-01en
dc.identifier.citationStroke; A Journal of Cerebral Circulation; 33(9): 2236-42en
dc.identifier.govdoc12215593en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9426en
dc.description.abstractIntracerebral hemorrhage is the most serious complication of thrombolytic therapy for stroke. We explored factors associated with this complication in the Australian Streptokinase Trial.The initial CT scans (< or =4 hours after stroke) of 270 patients were reviewed retrospectively by an expert panel for early signs of ischemia and classified into the following 3 categories: no signs or < or =1/3 or >1/3 of the vascular territory. Hemorrhage on late CT scans was categorized as major or minor on the basis of location and mass effect. Stepwise, backward elimination, multivariate logistic regression analysis was used to identify risk factors for each hemorrhage category.Major hemorrhage occurred in 21% of streptokinase (SK) and 4% of placebo patients. Predictors of major hemorrhage were SK treatment (odds ratio [OR], 6.40; 95% CI, 2.50 to 16.36) and elevated systolic blood pressure before therapy (OR, 1.03; 95% CI, 1.01 to 1.05). Baseline systolic blood pressure >165 mm Hg in SK-treated patients resulted in a >25% risk of major secondary hemorrhage. Early ischemic CT changes, either < or =1/3 or >1/3, were not associated with major hemorrhage (OR, 1.58; 95% CI, 0.65 to 3.83; and OR, 1.11; 95% CI, 0.45 to 2.76, respectively). Minor hemorrhage occurred in 30% of the SK and 26% of the placebo group. Predictors of minor hemorrhage were male sex, severe stroke, early CT changes, and SK treatment. Ninety-one percent of patients with major hemorrhage deteriorated clinically compared with 23% with minor hemorrhage.SK increased the risk of both minor and major hemorrhage. Major hemorrhage was also more likely in patients with elevated baseline systolic blood pressure. However, early CT changes did not predict major hemorrhage. Results from this study highlight the importance of baseline systolic blood pressure as a potential cause of hemorrhage in patients undergoing thrombolysis.en
dc.language.isoenen
dc.subject.otherAcute Diseaseen
dc.subject.otherAdulten
dc.subject.otherAgeden
dc.subject.otherAged, 80 and overen
dc.subject.otherBlood Pressureen
dc.subject.otherBrain Ischemia.complications.diagnosis.drug therapyen
dc.subject.otherCerebral Hemorrhage.chemically induced.radiographyen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherLogistic Modelsen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherMultivariate Analysisen
dc.subject.otherOdds Ratioen
dc.subject.otherPredictive Value of Testsen
dc.subject.otherRandomized Controlled Trials as Topicen
dc.subject.otherRetrospective Studiesen
dc.subject.otherRisk Assessmenten
dc.subject.otherRisk Factorsen
dc.subject.otherSex Factorsen
dc.subject.otherStreptokinase.adverse effects.therapeutic useen
dc.subject.otherStroke.complications.diagnosis.drug therapyen
dc.subject.otherTomography, X-Ray Computeden
dc.subject.otherTreatment Outcomeen
dc.titleBaseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke.en
dc.typeJournal Articleen
dc.identifier.journaltitleStrokeen
dc.identifier.affiliationNational Stroke Research Institute and University of Melbourne Department of Medicine, Austin and Repatriation Medical Centre, Heidelberg West, Victoria, Australiaen
dc.description.pages2236-42en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/12215593en
dc.contributor.corpauthorAustralian Streptokinase Trial Investigatorsen
dc.type.austinJournal Articleen
local.name.researcherChambers, Brian R
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptRadiology-
crisitem.author.deptNeurology-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.